MoCRA Facility Registration and Product Listing: A Walkthrough
For decades the United States treated cosmetics differently from drugs and food, with no pre-market registration and no product listing requirement. That has changed. The modernised framework now requires facilities to register, requires products to be listed, and requires records that did not previously exist. Brands selling into the US frequently assume the factory handles it. Most of the obligations actually rest with the brand.
Who Files What
The division is the first thing to get right, because two different parties have two different obligations and neither can do the other's job.
- Facility registration. Every facility that manufactures or processes a cosmetic product for distribution in the United States must register with the FDA, including foreign facilities. Registration is renewed on a recurring cycle and must be updated when the facility changes address or ownership.
- Product listing. The responsible person for the product must list each cosmetic product with the FDA. The listing includes the product name, the categories, the responsible person's details, the ingredients, and the facility registration number for each facility where it is made.
- Responsible person. The brand owner or the importer is generally the responsible person, not the contract manufacturer. This is the point most brands miss.
- Adverse event records. The responsible person must keep records of serious adverse events for a defined period and report them within a set number of days.
- Safety substantiation. The responsible person must maintain records showing the product is safe under labelled or customary conditions of use. There is no prescribed format, which makes it a documentary discipline rather than a form.
What a Small Brand Actually Has to Do
The practical checklist for a brand selling a private label line into the United States is shorter than the regulation sounds:
- Confirm with your manufacturer that the facility is registered and that you have the registration number in writing. Ask for it in the quotation or the first order confirmation rather than at the point of a customs enquiry.
- Prepare the product listing data: full ingredient list in the correct order, product category, pack size and the facility details.
- Decide who acts as responsible person for the US. If you are a foreign brand without a US establishment, this usually means an importer or a US entity.
- Set up an adverse event log with a defined retention period and a named owner. Even a simple spreadsheet with the date, the reporter, the product, the batch code and the outcome is enough to start.
- Assemble a safety substantiation file. Stability, microbiology, the safety assessment and the ingredient documentation are what will be looked for.
Special Categories That Carry Extra Requirements
Two categories sit outside the ordinary cosmetic framework. Products that make a therapeutic claim become drugs and fall under a different and much heavier regime. Talc containing products carry a specific testing and documentation obligation regarding asbestos content.
This is why claim discipline matters more in the United States than in many markets. A product described as treating acne, removing dark spots caused by a condition, or repairing damaged skin is not a cosmetic in the US, regardless of how it is formulated. For a factory this is a technical question. For a brand it is a question of which regulatory pathway the business is prepared to fund.
What It Means for Your Supplier Relationship
Because the brand carries the obligations, the documentation flow has to be agreed at the start. Three things should be in writing before the first production run:
- The FDA registration number of the facility, and confirmation that it is current.
- A commitment to notify the brand of any change in registration status, facility address or ownership.
- The full ingredient disclosure with percentages, and the safety and stability documentation the responsible person needs for safety substantiation.
Some factories regard the composition as confidential and will only release it under a confidentiality agreement or to a nominated assessor. That is reasonable, but it has to be resolved before the product is launched rather than during a compliance review.
Timelines and Practical Sequencing
Registration and listing are administrative and can be completed quickly once the data is available. What takes time is collecting the underlying documentation, particularly for a range with multiple SKUs, and especially where ingredients are supplied through a chain of traders rather than directly from producers.
The sequence that avoids bottlenecks is: freeze the formula and the pack, collect the ingredient documentation from every supplier including the chain-of-custody declarations, assemble the safety substantiation records, then file the listing once and update it when SKUs are added. Filing per SKU at launch and updating for each new variant keeps the record current and avoids a catch-up exercise at the end of the year.
How This Fits With an EU File
A brand selling into both markets should build one technical dossier and extract from it. The EU needs the PIF structure with a formal safety report; the US needs registration and listing plus safety substantiation records. The underlying composition, stability, microbiology and packaging evidence is largely the same. Commissioning it once and assembling it twice is significantly cheaper than running separate documentation projects.
US-Ready Documentation From a Registered Facility
OEM COSMETICS ODM manufactures on ISO 22716 and GMP certified lines and supplies facility registration details, full composition disclosure, stability and microbiological data and packaging compatibility records for US cosmetic compliance. Tell us your US sales channel at the brief stage and we will confirm which documents you need.
Talk to our team: WhatsApp +86 18709713948 · Email adon@oemcosmeticsodm.com · Website www.oemcosmeticsodm.com